Applied Molecular Transport Inc. announced the appointment of John W. Smither to its Board of Directors and Chair of its Audit Committee. AMT announced that current Director, Graham K. Cooper, has been named Executive Chair and current Director, Helen S. Kim, has been named Lead Independent Director. Mr. Smither most recently served as chief financial officer of Arcutis Biotherapeutics Inc. Prior to Arcutis, Mr. Smither was chief financial officer for Sienna Biopharmaceuticals.

Prior to joining Sienna Biopharmaceuticals, Mr. Smither was interim chief financial officer for Kite Pharma during its integration with Gilead.